Asia Pacific Hospital-Acquired Infection Diagnostics Market Size, Share & Industry Trends Analysis Report By Product (Reagents & Consumables and Instrument), By Infection Type, By Application, By Test Type, By End User, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Hospital-Acquired Infection Diagnostics Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).

Obtaining detailed information about the patient's medical history and completing a comprehensive physical examination is critical in evaluating whether the infection occurred before admission or was acquired in the hospital. Important details from the past, such as subjective temperature, chills, and night sweats, could imply that the infection was not caught in the hospital. Fever, altered mental status, chills, shortness of breath, productive cough, palpitations, abdominal discomfort, flank pain, polyuria, dysuria, suprapubic pain, and diarrhea are all common infection symptoms. Vital signs can reveal symptoms of sepsis or a systemic inflammatory reaction. Hypothermia or hyperthermia, tachycardia, tachypnea, and hypotension are examples. Tracheostomies, foley catheters, endotracheal tubes, intravascular lines, insulin pumps, and pacemakers/defibrillators must all be thoroughly examined. The information about the device's position and placement complement the evaluation of external devices (setting and duration).

Asia Pacific region is one of the regions that has been recording the patients that acquired the infections from the hospital itself and eventually get permanently disabled or sometimes die. Hospital-acquired infections (HAIs) pose a significant threat to patient safety and have significant public health implications, as it affect patients' quality of life and can sometimes result in death or permanent disability. The full cost of HAI, particularly in developing nations, is unknown.

As the government battles a recurrence of locally transmitted cases, China has stepped up measures to avoid infections in hospitals. For instance, according to a directive established by the State Council interagency working force for COVID-19 response, hospitals authorized for treating complicated cases should take aggressive measures to contain infections. All hospital-acquired infection cases, both locally and imported contracted, along with asymptomatic carriers, were admitted to recognized hospitals' isolation wards and kept segregated from patients with other kinds of diseases.

The China market dominated the Asia Pacific Hospital-Acquired Infection Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $463.6 million by 2028. The Japan market is poised to grow at a CAGR of 7.9% during (2022 - 2028). Additionally, The India market would display a CAGR of 9.2% during (2022 - 2028).

Based on Product, the market is segmented into Reagents & Consumables and Instrument. Based on Infection Type, the market is segmented into Urinary Tract Infections (UTI), Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, and Others. Based on Application, the market is segmented into Drug-Resistance Testing and Disease Testing. Based on Test Type, the market is segmented into Molecular Diagnostics, Immunoassay, and Urinalysis. Based on End User, the market is segmented into Hospital, Standalone Laboratories, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Hospital-Acquired Infection Diagnostics Market is Projected to reach USD 5.6 Billion by 2028, at a CAGR of 7.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG (Bayer Schering Pharma AG), Danaher Corporation, Becton, Dickinson and Company, Hologic, Inc., Ecolab, Inc., Pfizer, Inc., Steris PLC, Johnson & Johnson, Abbott Laboratories, and Merck Group.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Reagents & Consumables
• Instrument

By Infection Type

• Urinary Tract Infections (UTI)
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Others

By Application

• Drug-Resistance Testing
• Disease Testing

By Test Type

• Molecular Diagnostics
• Immunoassay
• Urinalysis

By End User

• Hospital
• Standalone Laboratories
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Bayer AG (Bayer Schering Pharma AG)
• Danaher Corporation
• Becton, Dickinson and Company
• Hologic, Inc.
• Ecolab, Inc.
• Pfizer, Inc.
• Steris PLC
• Johnson & Johnson
• Abbott Laboratories
• Merck Group

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Hospital-Acquired Infection Diagnostics Market, by Product
1.4.2 Asia Pacific Hospital-Acquired Infection Diagnostics Market, by Infection Type
1.4.3 Asia Pacific Hospital-Acquired Infection Diagnostics Market, by Application
1.4.4 Asia Pacific Hospital-Acquired Infection Diagnostics Market, by Test Type
1.4.5 Asia Pacific Hospital-Acquired Infection Diagnostics Market, by End User
1.4.6 Asia Pacific Hospital-Acquired Infection Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product
4.1 Asia Pacific Reagents & Consumables Market by Country
4.2 Asia Pacific Instrument Market by Country

Chapter 5. Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type
5.1 Asia Pacific Urinary Tract Infections (UTI) Market by Country
5.2 Asia Pacific Hospital Acquired Pneumonia Market by Country
5.3 Asia Pacific Bloodstream Infections Market by Country
5.4 Asia Pacific Surgical Site Infections Market by Country
5.5 Asia Pacific Gastrointestinal Infections Market by Country
5.6 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application
6.1 Asia Pacific Drug-Resistance Testing Market by Country
6.2 Asia Pacific Disease Testing Market by Country

Chapter 7. Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type
7.1 Asia Pacific Molecular Diagnostics Market by Country
7.2 Asia Pacific Immunoassay Market by Country
7.3 Asia Pacific Urinalysis Market by Country

Chapter 8. Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User
8.1 Asia Pacific Hospital Market by Country
8.2 Asia Pacific Standalone Laboratories Market by Country
8.3 Asia Pacific Others Market by Country

Chapter 9. Asia Pacific Hospital-Acquired Infection Diagnostics Market by Country
9.1 China Hospital-Acquired Infection Diagnostics Market
9.1.1 China Hospital-Acquired Infection Diagnostics Market by Product
9.1.2 China Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.3 China Hospital-Acquired Infection Diagnostics Market by Application
9.1.4 China Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.5 China Hospital-Acquired Infection Diagnostics Market by End User
9.2 Japan Hospital-Acquired Infection Diagnostics Market
9.2.1 Japan Hospital-Acquired Infection Diagnostics Market by Product
9.2.2 Japan Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.3 Japan Hospital-Acquired Infection Diagnostics Market by Application
9.2.4 Japan Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.5 Japan Hospital-Acquired Infection Diagnostics Market by End User
9.3 India Hospital-Acquired Infection Diagnostics Market
9.3.1 India Hospital-Acquired Infection Diagnostics Market by Product
9.3.2 India Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.3 India Hospital-Acquired Infection Diagnostics Market by Application
9.3.4 India Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.5 India Hospital-Acquired Infection Diagnostics Market by End User
9.4 South Korea Hospital-Acquired Infection Diagnostics Market
9.4.1 South Korea Hospital-Acquired Infection Diagnostics Market by Product
9.4.2 South Korea Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.3 South Korea Hospital-Acquired Infection Diagnostics Market by Application
9.4.4 South Korea Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.5 South Korea Hospital-Acquired Infection Diagnostics Market by End User
9.5 Singapore Hospital-Acquired Infection Diagnostics Market
9.5.1 Singapore Hospital-Acquired Infection Diagnostics Market by Product
9.5.2 Singapore Hospital-Acquired Infection Diagnostics Market by Infection Type
9.5.3 Singapore Hospital-Acquired Infection Diagnostics Market by Application
9.5.4 Singapore Hospital-Acquired Infection Diagnostics Market by Test Type
9.5.5 Singapore Hospital-Acquired Infection Diagnostics Market by End User
9.6 Malaysia Hospital-Acquired Infection Diagnostics Market
9.6.1 Malaysia Hospital-Acquired Infection Diagnostics Market by Product
9.6.2 Malaysia Hospital-Acquired Infection Diagnostics Market by Infection Type
9.6.3 Malaysia Hospital-Acquired Infection Diagnostics Market by Application
9.6.4 Malaysia Hospital-Acquired Infection Diagnostics Market by Test Type
9.6.5 Malaysia Hospital-Acquired Infection Diagnostics Market by End User
9.7 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market
9.7.1 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product
9.7.2 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type
9.7.3 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application
9.7.4 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type
9.7.5 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User

Chapter 10. Company Profiles
10.1 Bayer AG (Bayer Schering Pharma AG)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Partnerships, Collaborations and Agreements
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.1 Recent Strategies and Developments
10.3.1.1 Partnerships, Collaborations and Agreements
10.3.1.2 Product Launches and Product Expansions
10.4 Hologic, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent Strategies and Developments
10.4.5.1 Partnerships, Collaborations and Agreements
10.4.5.2 Product Launches and Product Expansions
10.5 Ecolab, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Geographical Expansions:
10.6 Pfizer, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional & Segmental Analysis
10.6.4 Research & Development Expense
10.6.5 Recent Strategies and Developments
10.6.5.1 Approvals and Trials:
10.6.5.2 Acquisitions and Mergers
10.7 Steris PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Johnson & Johnson
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental &Regional Analysis
10.8.4 Research & Development Expenses
10.9 Abbott Laboratories
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent Strategies and Developments
10.9.5.1 Approvals and Trials:
10.9.5.2 Product Launches and Product Expansions:
10.10. Merck Group
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent Strategies and Developments
10.10.5.1 Partnerships, Collaborations and Agreements

TABLE 1 Asia Pacific Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Hospital-Acquired Infection Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Hospital-Acquired Infection Diagnostics Market
TABLE 5 Acquisition and Mergers– Hospital-Acquired Infection Diagnostics Market
TABLE 6 Approvals and Trials - Hospital-Acquired Infection Diagnostics Market
TABLE 7 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Reagents & Consumables Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Reagents & Consumables Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Instrument Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Instrument Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Urinary Tract Infections (UTI) Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Urinary Tract Infections (UTI) Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Hospital Acquired Pneumonia Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Hospital Acquired Pneumonia Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Bloodstream Infections Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Bloodstream Infections Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Surgical Site Infections Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Surgical Site Infections Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Gastrointestinal Infections Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Gastrointestinal Infections Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Drug-Resistance Testing Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Drug-Resistance Testing Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 39 Asia Pacific Urinalysis Market by Country, 2018 - 2021, USD Million
TABLE 40 Asia Pacific Urinalysis Market by Country, 2022 - 2028, USD Million
TABLE 41 Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 42 Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 43 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
TABLE 44 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
TABLE 45 Asia Pacific Standalone Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 46 Asia Pacific Standalone Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 47 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 48 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 49 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 50 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 51 China Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 52 China Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 53 China Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 54 China Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 55 China Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 56 China Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 57 China Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 58 China Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 59 China Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 60 China Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 61 China Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 62 China Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 63 Japan Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 64 Japan Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 65 Japan Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 66 Japan Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 67 Japan Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 68 Japan Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 69 Japan Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 70 Japan Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 71 Japan Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 72 Japan Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 73 Japan Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 74 Japan Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 75 India Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 76 India Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 77 India Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 78 India Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 79 India Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 80 India Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 81 India Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 82 India Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 83 India Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 84 India Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 85 India Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 86 India Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 87 South Korea Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 88 South Korea Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 89 South Korea Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 90 South Korea Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 91 South Korea Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 92 South Korea Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 93 South Korea Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 94 South Korea Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 95 South Korea Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 96 South Korea Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 97 South Korea Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 98 South Korea Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 99 Singapore Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 100 Singapore Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 101 Singapore Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 102 Singapore Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 103 Singapore Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 104 Singapore Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 105 Singapore Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 106 Singapore Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 107 Singapore Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 108 Singapore Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 109 Singapore Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 110 Singapore Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 111 Malaysia Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 112 Malaysia Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 113 Malaysia Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 114 Malaysia Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 115 Malaysia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 116 Malaysia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 117 Malaysia Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 118 Malaysia Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 119 Malaysia Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 120 Malaysia Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 121 Malaysia Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 122 Malaysia Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 123 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 124 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 125 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 126 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 127 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 128 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 129 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 130 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 131 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 132 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 133 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 134 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 135 Key Information – Bayer AG
TABLE 136 Key Information – Danaher Corporation
TABLE 137 Key information – Becton, Dickinson and Company
TABLE 138 Key information – Hologic, Inc.
TABLE 139 Key Information – Ecolab, Inc.
TABLE 140 Key Information – Pfizer, Inc.
TABLE 141 key information – Steris PLC
TABLE 142 Key information – Johnson & Johnson
TABLE 143 Key Information – Abbott Laboratories
TABLE 144 key Information – Merck GrouP

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent Strategies and Developments: Becton, Dickinson and Company
FIG 5 Recent Strategies and Developments: Hologic, Inc.
FIG 6 Recent Strategies and Developments: Ecolab, Inc.
FIG 7 Recent Strategies and Developments: Pfizer, Inc.
FIG 8 Recent Strategies and Developments: Abbott Laboratories